Amyris, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Hermanus Kieftenbeld
- Full Time Employees
- 1,598
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Address
- 5885 Hollis Street EmeryVille CA United States of America 94608
- IPO Date
- Sep 28, 2010
- CIK
- 0001365916
- Website
- amyris.com
- Similar Companies
- Business
- Amyris, Inc. is a synthetic biology company specializing in industrial biotechnology and precision fermentation to produce sustainable, high-performance ingredients and consumer products. The company manufactures a diverse portfolio of market-ready bio-based ingredients and products through advanced fermentation technology. Its core product offerings include clean beauty and personal care ingredients such as squalane and emollients; flavors and fragrances; nutrition and wellness ingredients; performance materials; renewable specialty chemicals; and pharmaceutical and vaccine-related bioscience solutions. Amyris markets its consumer product brands including Biossance, JVN, Rose Inc., Pipette, Costa Brazil, Purecane, and others primarily in the beauty, health, wellness, and sustainability sectors. Founded in 2003 and headquartered in Emeryville, California, Amyris operates globally across North America, South America, Europe, and Asia. Recent major changes include Amyris emerging from Chapter 11 bankruptcy in early 2024 following the sale of its consumer brands, with a renewed strategic focus on its high-value technology and R&D assets in sustainable ingredient production. In May 2025, Amyris took full ownership of its Brazilian precision fermentation plant after acquiring Ingredion’s 31% stake in the RealSweet joint venture and invested in expanding fermentation capacity with the commissioning of a fourth production line. The company also launched two new consumer brands in 2025, enhancing its clean health and beauty portfolio using its proprietary Lab-to-Market platform that integrates machine learning, robotics, and artificial intelligence for rapid innovation scaling. Additionally, Amyris secured a $12.3 million agreement in 2024 to develop critical medicines through partnerships with US federal agencies, underscoring its expansion into pharmaceutical manufacturing. Amyris continues to leverage a vertically integrated model that combines synthetic biology, proprietary organism engineering, and commercial scalability to serve global industrial, pharmaceutical, flavors and fragrances, and clean beauty markets with sustainable, traceable products. Its CEO since 2024 is Kathy Fortmann, who has driven the company’s strategic pivot towards advanced biotechnology and sustainability innovation.
Amyris Takes Full Ownership of Brazilian Industrial Fermentation Plant and Invests in Completion of Fourth Precision Fermentation Line
Amyris and Ingredion Wind Down RealSweet Joint Venture
Squalene Market to Grow by USD 62.9 Million from 2024-2028, Driven by Rising Adoption of UVA/UVB Filters in Sunscreens, Report Powered by AI - Technavio
Retail investors flock to penny stocks WeWork, Amyris, Proterra
AMRS Stock Surges 152% as Amyris Files for Bankruptcy
Biotech Company Amyris Files for Bankruptcy
Why Is Amyris (AMRS) Stock Down 67% Today?
AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATION
Amyris Warns Of Potential Bankruptcy - Sell
7 Biotech Stocks to Sell in July
Is It Time to Buy This Year's Worst-Performing Growth Stocks?
Amyris: CEO's Exit Has Negative Implications
10 Top Penny Stocks To Watch Right Now For Under $1
Amyris: Company Separates From Long-Standing CEO Amid Ongoing Restructuring Efforts - Sell
Arctic Marine Response Station in Rankin Inlet open for the season
3 Hot Penny Stocks To Watch Before Next Week
3 Penny Stocks Under $1 To Watch This Week; Time To Buy?
Hot Penny Stocks To Watch After UCAR Stock Explodes
OTTO Motors Unveils North American Sales and Service Expansion With OTTO Certified Dealers
Big Joe Debuts New AMR Features & Capabilities at Automate 2023